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Abstract 
Background: The transmission of malaria to mosquitoes depends on the presence of gametocytes that circulate in 
the peripheral blood of infected human hosts. Sensitive estimates of the densities of female gametocytes (FG) and 
male gametocytes (MG) may allow the prediction of infectivity to mosquitoes and thus a molecular estimate of the 
human infectious reservoir for transmission.
Methods: A novel multiplex qRT‑PCR assay with intron‑spanning primers was developed for the parallel quantifica‑
tion of FG and MG. CCp4 (PF3D7_0903800) transcripts specific for FG and PfMGET (PF3D7_1469900) transcripts specific 
for MG were quantified in total nucleic acids. The assay was validated on sex‑sorted gametocytes from culture mate‑
rial and on samples from clinical trials with gametocytocidal drugs. Synthetic RNA standards were generated for the 
two targets genes and calibrated against known gametocyte quantities.
Results: The limit of detection was determined at 0.1 male and 0.1 female gametocyte/µL, which was equal to 
the limit of quantification (LOQ) for MG, while the LOQ for FG was 1 FG/µL. Results from previously reported clinical 
trials that used separate gametocyte qRT‑PCR assays for FG (targeting Pfs25) and MG (targeting PfMGET) were repro‑
duced with the multiplex assay. High levels of agreement between separate assays and the multiplex approach were 
observed  (R2 = 0.9473, 95% CI 0.9314–0.9632, for FG measured by transcript levels of Pfs25 in qRT‑PCR or CCp4 in mul‑
tiplex;  R2 = 0.8869, 95% CI 0.8541–0.9197, for MG measured by PfMGET in either single or multiplex qRT‑PCR). FG and 
MG transcripts were detected in pure ring stage parasites at 10,000‑ and 100,000‑fold reduced frequency for CCp4 and 
PfMGET, respectively. The CCp4 and PfMGET transcripts were equally stable under suboptimal storage conditions.
Conclusions: Gametocyte densities and their sex ratios can be determined in the presented one‑step multiplex 
assay with higher throughput than single assays. The interpretation of low gametocyte densities at asexual parasite 
densities above 1000 parasites/µL requires caution to avoid false positive gametocyte signals from spurious transcript 
levels in ring stage parasites.
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Background
The significant reduction in malaria mortality and 
morbidity seen in the last 10 years is the result of com-
bined efficient control measures such as early diag-
nosis, effective treatment with artemisinin-based 
combination therapy (ACT), active surveillance and vec-
tor control. Nevertheless, in 2016, 216 million cases were 
still reported worldwide [1] and major concerns exist 
about the extent to which the emergence and spread of 
insecticide [2] and artemisinin resistance [3] may affect 
worldwide malaria control and elimination efforts. New 
strategies may be needed to sustain recent gains and 
accelerate malaria elimination initiatives. These new 
strategies include the development and deployment 
of transmission-blocking strategies that aim to reduce 
malaria incidence by targeting the infection reservoir 
involved in maintaining parasite transmission from 
humans to Anopheles mosquitoes.
Transmission to mosquitoes is mediated by the pres-
ence of gametocytes in peripheral blood of a human host. 
Gametocytes are sexually dimorphic and both sexes are 
required to ensure the development of the parasite inside 
the mosquito. Although the likelihood of mosquito infec-
tion is largely dictated by gametocyte density [4], the 
gametocyte sex ratio may also play a significant role in 
ensuring fertilization [5–7]. Since one female gametocyte 
(FG) produces only one gamete, while a male gametocyte 
(MG) produces eight gametes [8, 9], the gametocyte sex 
ratio is usually female-biased in the proportion of 3–5 
females: 1 male [10, 11] with indications from rodent 
malarias and natural Plasmodium falciparum infections 
that sex ratios may be adjusted in the presence of other 
parasite clones [6, 12], in relation to gametocyte density 
[7, 13] during infections and in response to environmen-
tal factors, such as anaemia [10]. Recent findings further 
suggest that anti-malarial drugs may have differential 
effects on MG and FG [14, 15]. Understanding game-
tocyte sex ratios is thus of interest to understand Plas-
modium biology, better predict transmission potential 
during natural malaria infections and estimate the likeli-
hood of onward transmission to mosquitoes after treat-
ment with anti-malarial drugs.
Gametocytes usually circulate in blood at low levels 
as only 0.2–1% of asexual parasites commit to sexual 
development at every cycle of red blood cell invasion 
[16]. Several studies have observed infected mosquitoes 
after feeding on blood containing gametocyte densities 
as low as 0.25–0.3 gametocytes/microlitre of blood, well 
below the threshold for detection by routine microscopy 
[7, 17–21]. As a consequence of the abundant presence 
of submicroscopic densities of gametocytes in clinical 
and asymptomatic infections [22–24], they represent a 
silent infectious reservoir in the population. In the last 
20 years, sensitive molecular techniques based on sexual 
stage-specific mRNA transcripts have been developed to 
improve the detection and quantification of both game-
tocyte sexes. Pfs25 mRNA has been widely used as a 
mature gametocyte marker [19–21, 25] and was recently 
confirmed to be female-specific or at least consider-
ably female-biased [26, 27]. Based on RNA-seq analysis, 
PfMGET was recently presented as a novel male-specific 
gametocyte marker [26, 28]. The use of intron-spanning 
primers allows for sensitive detection of MG in sam-
ples of naturally infected parasite carriers [28]. Thus far 
a combination of separate Pfs25 and PfMGET qRT-PCR 
assays has been used to estimate gametocyte sex ratios 
in natural and controlled infections [7, 15, 28–30]. How-
ever, estimating sex ratios by using two separate qRT-
PCR assays may affect assay precision and throughput. 
Here, a novel target for FG is proposed, CCp4, that was 
previously identified as a gametocyte-specific transcript 
[31] and allows for intron-spanning primer design. This 
manuscript describes a one-step multiplex qRT-PCR 
assay for robust assessments of gametocyte sex ratios at 
densities below the microscopic threshold for gameto-
cyte detection.
Methods
Selection of male and female marker transcript
The selection of the male marker PfMGET was described 
previously [28]. The female marker CCp4 was identi-
fied by integrating transcriptomics data and validated as 
gametocyte-specific [31].
Preparation of gametocyte material
Sex-sorted gametocytes were generated as described 
previously [26, 28]. In brief, cultures of the PfDynGFP/
P47mCherry line [26] were treated with N-acetyl glu-
cosamine and stage V gametocytes were FACS sorted for 
their fluorescence signal (MG are sorted as GFP-positive/
mCherry-negative, FG as mCherry-positive/GFP-nega-
tive) and afterwards counted with a Bürker-Türk count-
ing chamber. For both MG and FG tenfold dilution series 
were prepared in whole-blood in the range of  106/mL to 
 101/mL and stored in RNAProtect to serve as standard 
curves for gametocyte quantification.
Preparation of ring stage parasites to assess transcript 
stage specificity
Asexual parasites of the NF54 strain were synchronized 
by the selection of late trophozoites and schizonts as 
described [28]. In brief, a 63% Percoll density gradi-
ent was followed by a 5% sorbitol treatment, killing the 
remaining schizonts after 5  h and ensuring tight syn-
chronization. NF54 ring stage parasites were harvested 
10–20  h after the Percoll treatment and stored in lysis 
Page 3 of 11Meerstein‑Kessel et al. Malar J          (2018) 17:441 
buffer (5.25 M GuSCN; 50 mM Tris–HCl pH6.4; 20 mM 
EDTA; 1.3% Triton X-100) for later analysis.
To obtain pure asexual stage reference material without 
plausible contamination by gametocytes, ring stage para-
sites of the gametocyte-deficient F12 clone were used that 
have a loss-of-function mutation in the gene encoding 
the gametocyte master transcription factor AP2-G [32]. 
In addition, ring stage parasites were generated from the 
recently described AP2-G knock-down line 3D7/AP2-G-
GFP-DDglmS that does not express AP2-G when grown 
in the presence of 2.5  mM (d)-+-glucosamine (GlcN) 
(Sigma Aldrich) [33]. Under these conditions both the 
ap2-g-gfp-dd transcript and AP2-G-GFP-DD protein are 
degraded, resulting in no gametocyte production. Para-
sites were synchronized twice 16 h apart to obtain an 8-h 
growth window. 30 mL parasite culture at 3–4% parasi-
taemia and 5% haematocrit was harvested at 8–16 h post 
invasion. Parasites were released from infected RBCs by 
saponin lysis and total RNA was directly isolated using 
Ribozol (Amresco) according to the manufacturer’s 
manual.
Samples from naturally infected gametocyte carriers
Samples from two previously published clinical trials 
in light microscopy-positive gametocyte carriers from 
Kenya [28] and Mali [15] were used to directly compare 
gametocyte density estimates using the PfMGET/CCp4 
multiplex assay with the previous qRT-PCR assays tar-
geting PfMGET (male) and Pfs25 (female) transcripts 
separately. The multiplex assay was performed on Ken-
yan samples collected prior to treatment (day 0; n = 31), 
and after treatment on day 2 (n = 16), day 7 (n = 46), and 
day 14 with dihydroartemisinin–piperaquine (DP) alone 
or with primaquine (n = 28; total n = 121). The samples 
from Mali that were included in the current study were 
collected on day 7 after treatment with either DP (n = 15) 
or DP + methylene blue (15  mg/kg given daily for the 
first 3  days of treatment; DP + MB, n = 19) or sulfadox-
ine–pyrimethamine and amodiaquine (SP–AQ, n = 19) 
or SP–AQ with a single dose of primaquine (0.25  mg/
kg given together with the first dose of SP–AQ, SP–
AQ + PQ, n = 19) [15]. In both studies considerable varia-
tion in gametocyte densities and sex ratios was previously 
reported.
Nucleic acid extraction and target amplification
Total nucleic acids were extracted from 50  µL whole 
blood in five volumes RNAProtect with the MagNAPure 
LC automated extractor (Roche) using the MagNAPure 
LC Total Nucleic Acid Isolation Kit—High Performance, 
with the exception of F12- and 3D7/AP2-G-GFP-DDg-
lmS-derived material (bulk Ribozol (Amresco) extrac-
tion according to the manufacturer’s manual). Total 
nucleic acids were eluted in 50  µL of MagNAPure elu-
tion buffer, of which 5  µL was used in the multiplex 
assay. For the multiplex assay, we used the  Luna® Uni-
versal Probe One-Step RT-qPCR Kit (NEB). Gene IDs of 
the male and female markers and respective primer and 
probe sequences can be found in Table 1, for additional 
primer sequences see Additional file 1. Probe and primer 
concentrations were optimized (see Additional file 1) to 
obtain efficient amplification of both targets. The opti-
mal conditions are summarized in Table 2. Negative con-
trols were run to ensure there were no unspecific signals 
detected from no-template controls, or from total nucleic 
acids without reverse transcription (intron-spanning 
primers do not bind to genomic DNA); and melt curves 
were visually inspected. 
Serial dilutions of all ring stage materials were used 
to detect ring stage transcripts (SBP-1) and early 
Table 1 Primer and probe sequences for qRT-PCR assays, with references for earlier reported methods and primers
MPX multiplex assay, qRT-PCR quantitative real time reverse transcription‑PCR
*Intron‑spanning
Gene ID
Name
Fwd primer seq
Rev primer seq
Probe seq Fluoro-phore
PF3D7_1031000
Pfs25 [36]
GAA ATC CCG TTT CAT ACG CTTG 
AGT TTT AAC AGG ATT GCT TGT ATC TAA 
– –
PF3D7_1031000
Pfs25 [34]
6FAM‑ccgtttcatacgcttgtaa‑MGB FAM
PF3D7_0903800
CCp4 (MPX)
CAC ATG AAT ATG AGA ATA AAA TTG *
TAG GCG AAC ATG TGG AAA G
AGC AAC AAC GGT ATG TGC CTT AAA ACG Texas Red
PF3D7_0903800
CCp4 (qRT‑PCR)
CAC ATG AAT ATG AGA ATA AAA TTG *
TAG GCG AAC ATG TGG AAA G
– –
PF3D7_1469900
PfMGET (MPX)
CGG TCC AAA TAT AAA ATC CTG*
TGT GTA ACG TAT GAT TCA TTTTC 
CAG CTC CAG CAT TAA AAA CAC FAM
PF3D7_1469900
PfMGET (qRT‑PCR, [28])
CGG TCC AAA TAT AAA ATC CTG*
GTG TTT TTA ATG CTG GAG CTG 
– –
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gametocyte transcripts (Pfg27, Pfs16, Pfg14-744, Pfg14-
748) as well as the mature gametocyte transcripts CCp4, 
PfMGET and Pfs25. Total nucleic acids were used for the 
intron-containing genes SBP-1, Pfg14-744, Pfg14-748, 
CCp4 and PfMGET while Pfs16, Pfg27 and Pfs25 required 
RQ1 DNase I treatment (Promega). cDNA was prepared 
with the High Capacity cDNA Reverse Transcription Kit 
(Applied BioSystems) and 2 μL of cDNA was run in the 
GoTaq qPCR Master Mix (Promega). All primers were 
used at 900  nM, except for SBP1, PfMGET and Pfs25 
which were run at 225 nM primers.
Synthetic RNA standard curve material
Linear dsDNA templates for the target regions of CCp4 
and PfMGET were synthesized by BaseClear B.V. the 
Netherlands (for sequences, see Additional file  2) and 
purified by agarose gel electrophoresis. Bulk RNA was 
transcribed with the MEGAShortscript T7 high yield 
transcription kit (Invitrogen) at 10–50 nM dsDNA input 
according to the manufacturer’s instructions. Transcrip-
tion samples were DNaseI treated with the TURBO 
DNA-free kit (Invitrogen) and subsequently purified over 
an RNeasy mini spin column (Qiagen). RNA standards 
were calibrated against sex-sorted gametocyte standards, 
both standards were prepared using tenfold serial dilu-
tions. Copy numbers in initial samples were quantified on 
a Qubit 2 (ThermoFisher), absolute RNA amounts were 
calculated into copy numbers with the specific sequence 
weight.
Gametocyte transcript stability testing
Synchronized mature gametocytes (NF54, 1.8% parasi-
taemia) were diluted in whole EDTA-blood starting at 
concentrations of  105  gametocytes/mL. These samples 
were either stabilized by adding five volumes of RNAP-
rotect (Qiagen) or left unstabilized (no protective buffer 
added) for further treatments: One to three aliquots 
were kept at room temperature (22–25  °C) for 0 h, 1 h, 
2 h, 4 h, 6 h, 8 h or 24 h before freezing them at − 80 °C 
and subsequent processing. A subset of samples (n = 3) 
in RNAProtect (added at 0  h) were additionally freeze–
thawed five times (37  °C/− 80  °C cycling for at least 1 h 
each) before extraction of nucleic acids. The stability of 
the transcripts after extraction was also tested by freeze–
thaw cycles at which the samples were left at room tem-
perature (22–25  °C) or 37  °C for 1 h, interspersed by at 
least 1 h at − 20 °C.
Statistical analysis
Graphs and statistical analyses were made with Graph-
Pad Prism (version 5.0.3) or R statistical software (ver-
sion 3.4.0). The concordance between separate qRT-PCR 
assays and the multiplex approach was assessed by esti-
mating the slope and 95% confidence interval (95% CI) in 
linear regression. No statistical comparisons were made 
on the CT values of different marker genes since this was 
beyond the scope of the current manuscript and mean-
ingful comparisons would require a larger number of 
replicates. Where transcript abundance differences were 
estimated, this was based on the assumption of doubling 
of transcript after each cycle (1 Ct difference), regardless 
of reaction efficiencies.
Results
Male and female gametocyte transcripts are detected 
in low densities of gametocytes
A multiplex assay was developed to target the female- 
and male-specific gametocyte transcripts CCp4 and 
PfMGET simultaneously by intron-spanning primers. 
Amplification from genomic DNA was absent when 
qRT-PCRs were performed without reverse transcrip-
tion. Protocol optimization included limiting the primer 
concentration for the male target, which is explained in 
detail in Additional file  1 and resulted in an assay with 
two equally efficient amplification reactions for both tar-
get transcripts. Sorted MG and FG of the NF54-derived 
fluorescent reporter line PfDynGFP/PfP47mCherry 
[26] were used in dilution series to determine the limit 
of detection (LOD), limit of quantification (LOQ) and 
variation in the multiplex assay. In an octuplicate run of 
female and male standard curve material, the coefficient 
of within-run variation was assessed (Fig. 1a, b), which is 
very low (2–3%) for both target transcripts at high game-
tocyte densities, but increasing to 6% or 29% at densi-
ties of 100 sex-sorted gametocytes/mL for PfMGET and 
CCp4, respectively. The LOD is 100 MG or FG/mL (0.1/
µL) with 96.2% or 100% of all experiments at this density 
(n = 26) positive for PfMGET or CCp4, respectively. Even 
at 10 MG/mL (0.01 MG/µL), the male signal was detected 
in the majority of experiments (18 of 26, 69.2%), but with 
an increased variation coefficient (18%). The LOQ was 
hence equal to the LOD for MG  (102 MG/mL or 0.1 MG/
µL) while for FG the LOD was  102  FG/mL (0.1  FG/µL) 
and the LOQ was higher  (103 FG/mL or 1 FG/µL).
Table 2 Multiplex conditions for male–female assay
Concentration Program
Female primers CCp4 900 nM 55 °C 15 min RT‑step
Female probe—Texas Red 200 nM 95 °C 1 min
Male primers PfMGET 225 nM 95 °C 10 s 45 cycles
Male probe—FAM 200 nM 60 °C 1 min
Input total nucleic acid 5 µL
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Low densities of male and female gametocyte transcripts 
are detected in high densities of asexual parasites
Whilst previous studies reported negligible Pfs25 and 
male gametocyte transcripts in asexual (ring stage) 
parasites [25, 34, 35], low levels of CCp4, Pfs25 and 
PfMGET transcripts were detected in pure asexual par-
asite material (Fig. 2). About 10,000 ring stage parasites 
from the gametocyte-deficient F12 P. falciparum line 
[32] provided a similar quantity of CCp4 transcript as 
one FG and 100,000 F12 ring stages carried PfMGET 
transcript equivalent to one MG. In addition, ring stage 
parasites also contained Pfs25 transcripts. Their con-
centration was about 100,000-fold less than FG (Addi-
tional file 1: Figure S2A). Interestingly, compared to F12 
ring stages the expression of these gametocyte markers 
in ring stages of the 3D7/AP2-G-GFP-DDglmS line 
[33] was slightly lower when AP2-G was not expressed. 
Under these conditions, the fold-change in transcript 
between asexual rings and FG increased to 50,000-fold 
for CCp4 and to 200,000- to 300,000-fold for PfMGET 
(MG over asexual rings). Ring stage material of the 
F12 line and 3D7/AP2-G-GFP-DDglmS was then com-
pared with the gametocyte-producing NF54 line for the 
expression of markers that are transcribed from or at 
onset of sexual differentiation (Pfg27, Pfs16, Pfg14-744 
and Pfg14-748). The results indicate low-level contami-
nation with early gametocytes in NF54 compared to 
both gametocyte-non producing lines. Consistently, all 
Fig. 1 Limit of detection and variation of the gametocyte multiplex assay. Individual results of 8 technical replicates for female‑sorted (a) and 
male‑sorted (b) gametocytes of decreasing densities. Seven measurements (dots) obtained by calculating the reference from one randomly chosen 
dilution series. The coefficient of variation (filled bars) was calculated as standard deviation/mean of the respective calculated densities. Sample 
positivity in n = 26 independent experiments is indicated in the white boxes
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Fig. 2 Stage‑specificity of the multiplex assay. Female‑specific (a) and male‑specific (b) transcripts are detected in high concentrations of ring 
stage parasites of the F12 line and the 3D7/AP2‑G‑GFP‑DDglmS line). Mean Ct values ± 2SD for varying numbers of independent experiments: 
n = 2 and n = 9 for CCp4 in ring stage parasites and female gametocytes; n = 2 and n = 17 for PfMGET in ring stage parasites and male gametocytes, 
respectively. NA not available/not measured (samples at these concentrations were not available), ND not detected. Lines represent fitted linear 
regression curves
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markers were expressed at higher levels in NF54 ring 
stages compared to F12 and 3D7/AP2-G-GFP-DDglmS 
(Additional file 1: Figure S3).
The measured background expression of PfMGET 
and CCp4 transcripts in asexual ring stages leads to the 
following precautions, based on a conservative estimate 
of fold change of transcript levels (compared to F12 
rings): for the detection of MG and FG, the presence of 
asexual parasites at densities above 1000  parasites/µL 
can result in a false-positive signal for FG whilst asex-
ual parasites at densities above 10,000 parasites/µL can 
also result in a false-positive signal for MG (Table 3).
Both CCp4 and PfMGET were also moderately 
expressed in the opposite-sex gametocyte, detectable 
at concentrations of 10,000/mL or higher (Fig.  3). The 
opposite sex (MG) accounted for 0.1% (1 in 1000) false 
positive FG with CCp4 (Fig.  3a), and about every 100 
FG accounted for 1 MG (1% false positives) in PfMGET-
based detection (Fig. 3b). Pfs25 shows higher background 
than CCp4 in the opposite sex: 0.5% (1 in 200, Additional 
file 1: Figure S2B).
The male/female gametocyte multiplex assay corroborates 
earlier density estimates in naturally infected individuals
Estimates of MG and FG are highly correlated with the 
estimates obtained by Pfs25 qRT-PCR (FG for Kenya and 
Mali combined,  R2 = 0.9473, p < 0.001) and PfMGET qRT-
PCR (MG combined,  R2 = 0.8869, p < 0.001) (Fig.  4a, b) 
using a selection of samples from clinical trials in Kenya 
(n = 84 samples) [28] and Mali (n = 72 samples) [15]. In 
the Malian study [15], extreme gametocyte sex ratios 
were reported and multiplex qRT-PCR-estimates for 
sex-specific gametocyte densities (Fig. 4a, b), prevalence 
(Fig. 4c) and sex ratios (Fig. 4d) were in agreement with 
the conventional quantification by qRT-PCR targeting 
Pfs25 for FG [36] or PfMGET transcripts for MG [28].
A linear regression curve was fitted for single versus 
multiplex assay density estimates. For the MG quanti-
fication, there were indications that the slope deviated 
Table 3 The consequences of  low level gametocyte 
transcripts in  asexual parasites and  gametocytes 
of  the  opposite sex for  assessing gametocyte prevalence 
and density
Numbers in italics are above the limit of detection. Other estimates are 
presented to illustrate the marginal impact of signal derived from asexual 
parasites on gametocyte quantification. The false positive signal strength for 
female (FG, CCp4) and male target (MG, PfMGET) is based on the comparison of 
NF54 (sorted) gametocytes and F12 ring stages
Asexual parasite density False positive signal 
in gametocyte 
quantification
Trust 
prevalence/
estimated 
density 
if density 
is significantly 
above
Log10/mL FG MG FG MG
4 10/µL 0.001/µL 0.0001/µL Any Any
5 100/µL 0.01/µL 0.001/µL Any Any
6 1000/µL 0.1/µL 0.01/µL 0.1/µL Any
7 10,000/µL 1/µL 0.1/µL 1/µL 0.1/µL
8 100,000/µL 10/µL 1/µL 10/µL 1/µL
18
20
22
24
26
28
30
32
34
36
38
40
Sorted gametocytes/mL
10^3 10^4 10^5 10^6
FG (n=4)
MG (n=17)
Ct
 v
al
ue
20
22
24
26
28
30
32
34
36
38
40
42
Sorted gametocytes/mL
10^3 10^4 10^5 10^6
MG (n=3)
FG (n=9)
CCp4 PfMGET
ND
ND
a b
Fig. 3 Sex‑specificity of the multiplex assay. Female‑specific (a) and male‑specific (b) transcripts are detected in high concentrations of 
gametocytes of the opposite sex (empty symbols). Mean Ct values ± 2SD for varying numbers of independent experiments: n = 3 and n = 9 for 
CCp4 in male and female gametocytes; n = 4 and n = 17 for PfMGET in female and male gametocytes, respectively. ND not detected. Lines represent 
fitted linear regression curves
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from 1 (95% CI 0.7744–0.9507 for the study in Kenya and 
0.8633–0.9800 for the study in Mali) but resulting esti-
mates in sex ratio were highly similar to those obtained 
after separate qRT-PCR (Fig. 4d).
Male and female targets show similar stability 
under sub-optimal sample storage conditions
Differences in transcript stability upon delays in sample 
processing or following freeze–thaws may affect gameto-
cyte quantification of field samples. To resemble freshly 
taken blood samples with delays in sample processing, 
whole blood samples with NF54 parasites containing 
a mix of male and female gametocytes were stored at 
room temperature (22–25  °C) without an RNA-protect-
ing agent. Transcript abundance of CCp4, PfMGET and 
Pfs25 was determined at baseline (0 h) and after 1 h, 2 h, 
4 h, 6 h, 8 h or 24 h. All targets had stable Ct values after 
1 h without RNA-protecting agent (n = 1). PfMGET and 
CCp4 showed delayed Ct values after 2  h without pro-
tection (n = 2, Additional file 1: Figure S4). To study the 
effect of freezing/thawing after storage, blood was stored 
in RNAprotect and subjected to five freeze–thaw cycles 
at 37 °C prior to nucleic acid extraction. A minimal tran-
script loss was observed (0.523 and 0.245 Ct difference to 
baseline for PfMGET and CCp4, respectively, Additional 
file 1: Table S1). Extracted total nucleic acids were more 
stable and showed no loss in signal (0.08 and 0.02 Ct 
reduction) compared to baseline for PfMGET and CCp4, 
after five freeze–thaw cycles at room temperature for the 
sorted trend line material (Additional file 1: Table S1).
Synthetic RNA standards can be used to estimate 
gametocyte densities and copy numbers per gametocyte
In vitro-synthesized RNA of the target regions of CCp4 
and PfMGET was used in serial dilutions alongside 
sorted gametocyte standards (see Additional file  1: Fig-
ure S5A, B). The synthetic RNA standards were used to 
estimate the copy numbers in the gametocyte reference 
material (see Additional file 1: Figure S5C–E). For CCp4, 
estimated transcript copies were 4 (95% CI 3.2–5.1) 
mRNA copies per female gametocyte and for PfMGET 
9.8 (95% CI 8.9–10.2) copies per male gametocyte. For 
Fig. 4 Performance of the multiplex‑assay on clinical trial samples. a, b Agreement with previously measured gametocyte densities with 
single assays, using Pfs25 (a) and PfMGET (b) transcripts. The linear regression was fitted as follows [95% confidence interval]: for FG y = 0.9944 
[0.9497–1.040]x + 0.0751 [− 0.0627 to 0.2130] [28], y = 1.033 [0.977–1.092]x − 0.2554 [0.4619–0.04893] [15] and for MG y = 0.8626 [0.7744–0.9507]
x + 0.5919 [0.2802–0.9037] [28], y = 0.9217 [0.8633–0.9800]x + 0.3508 [0.1515–0.5500] [15]. c Gametocyte prevalence as determined by single or 
multiplex qPCR for four treatment arms (Dicko et al. 2018), 7 days after treatment with either DP, dihydroartemisinin–piperaquine (n = 15); DP + MB, 
dihydroartemisinin–piperaquine + methylene blue (n = 19); SP–AQ, sulfadoxine–pyrimethamine and amodiaquine (n = 19) or SP–AQ and a single 
dose of primaquine (n = 19). d Sex ratios of gametocytes determined by multiplex or individual qPCR; samples as in c 
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comparison, female gametocytes had an average of 231.7 
(95% CI 199.1–269.8) Pfs25 copies per gametocyte.
Discussion
In the current study, a multiplex assay for the rapid quan-
tification of female and male gametocytes is reported. 
The assay utilizes a new female gametocyte marker 
CCp4 in conjunction with the reported male gameto-
cyte marker PfMGET [28]. The use of intron-spanning 
primers allows simultaneous quantification of male and 
female-specific transcript levels in total nucleic acids 
without prior DNase I treatment. The presented analysis 
concludes low but non-negligible gametocyte transcripts 
in gametocytes of the opposite sex and gametocyte-free 
ring-stage asexual parasites. The stability of CCp4 and 
PfMGET transcripts was similar under suboptimal stor-
age conditions; gametocytes can be reliably detected and 
quantified at densities 0.1–1 gametocyte/μL.
CCp4 is a member of the LCCL-domain containing 
adhesion protein family and orthologous to LAP6 in 
Plasmodium berghei, where this gene is reported to be 
translationally repressed with protein expression occur-
ring at the ookinete stage only [37]. Earlier, a DOZI 
(development of zygote inhibited) knock out indicated 
that LAP6 transcripts (then called PB000955.03.0) are 
accumulated in an mRNA storage complex [38]. In P. fal-
ciparum, the CCp4 protein is predominantly expressed 
at the gametocyte stage, with only minor expression in 
male gametocytes [39] and no evidence for translational 
repression. Gametocyte-specific CCp4 transcripts were 
reported in an integrated analysis of eight Plasmodium 
transcriptomes [31]. The initial validation in qRT-PCR 
experiments confirmed CCp4 expression to be at least 
1000-fold upregulated in gametocytes of different P. fal-
ciparum strains compared to asexual blood stages. The 
1000-fold higher mRNA levels in FG over MG reported 
here confirm and exceed the previous estimates by 
RNAseq (38-fold higher in females by RPKM values) [26].
Unlike the commonly used female marker Pfs25, CCp4 
allows the design of intron-spanning primers. The cur-
rent assay utilizes intron-spanning primers of both male 
and female reporter genes with two marker-specific 
probes. Importantly, the multiplex gametocyte assay 
can be performed on total nucleic acids without DNase 
I treatment, which may affect gametocyte detection at 
low densities [28, 36]. The multiplex male–female assay 
is thus faster than separate assays. Sensitivity for detect-
ing female gametocyte was lower than for the single qRT-
PCR targeting Pfs25, which is at least in part explained 
by a lower estimated number of CCp4 transcripts per 
female gametocyte as compared to Pfs25. The LOD for 
female and male gametocytes in the multiplex assay is 
0.1/μL, well below the limit of microscopic detection and 
in the same range as other molecular sex-specific assays 
[28, 34, 35]. More sensitive total gametocyte assays have 
been reported [40] but the current multiplex LOD allows 
for the detection of infections that are likely to be trans-
missible to mosquitoes. An increasing likelihood of mos-
quito infections is consistently observed at gametocyte 
densities above 1–5 gametocyte per microlitre [7, 29, 41]. 
The current assay reliably quantifies gametocytes at these 
densities. The lower sensitivity to detect female gameto-
cytes as compared to Pfs25 may be a concern in studies 
where very low overall gametocyte densities are observed 
[29, 30] but the operational attractiveness of a multiplex 
assay that does not require DNase treatment is consider-
able for many other studies.
Previous work indicated that the stability of transcripts 
is a relevant concern when estimating gametocyte preva-
lence or density [36, 41]. When assessing gametocyte sex 
ratio, transcript stability is a particular concern since dif-
ferences in the stability between target transcripts may 
affect bias estimates. In a limited set of experiments 
there were no indications for differences in the stabil-
ity of PfMGET and CCp4 transcripts, provided samples 
are transferred to RNA-protective buffer within 1–2 h of 
blood collection. Freeze–thaw cycles resulted in limited 
RNA loss once blood samples are in this protective buffer. 
A similar stability of male or female signal is of particu-
lar relevance for studies conducted in low resource set-
tings where there may be challenges in ensuring optimal 
storage conditions. Repeated or prolonged freeze–thaw 
cycles may thus affect overall gametocyte detection or 
quantification [41, 42] but current results indicate they 
would not disproportionally affect MG or FG quantifica-
tion and thus sex-ratio estimates.
The presented multiplex assay is a fast route to accurate 
P. falciparum sex ratio determination, saving about 25% 
of the time—with similar material costs—compared to 
two separate assays of which one requires a DNase treat-
ment step. Medium sample through-put in 96-well for-
mat is the recommended application, providing accurate 
gametocyte quantification and sex ratio determination 
for blood and culture samples.
Previous studies concluded no or negligible Pfs25 tran-
script numbers in asexual parasites. In the current set of 
experiments, we detected gametocyte transcripts in dif-
ferent preparations of ring-stage asexual parasite mate-
rial. Whilst low-level contamination of gametocytes in 
supposedly pure asexual parasites may have contributed 
to the detection of CCp4, Pfs25 and PfMGET transcripts 
in asexual parasite material from the NF54 strain, the 
detection of these transcripts in the gametocyte-deficient 
F12 line and under knock-down conditions for AP2-G 
in a more recent gametocyte-less line 3D7/AP2-G-GFP-
DDglmS [33] provides convincing evidence for low-level 
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expression of Pfs25, CCp4 and PfMGET in asexual ring 
stage parasites. The current findings of detectable tran-
script expression for all gametocyte markers in high den-
sities of asexual blood stages despite different strategies 
to avoid gametocyte contamination have implications 
for past and future gametocytaemia estimates. Whilst 
the difference in transcript abundance between gameto-
cytes and asexual parasites is sufficiently pronounced to 
conclude a marginal impact on gametocyte density esti-
mates, gametocyte prevalence estimates may be inflated 
in some populations. Given the high parasitaemia of 
some acute malaria infections (with densities typically 
above 10,000  parasites/µL [43] as opposed to asympto-
matic infections where densities commonly lie below 
10  parasites/µL [44]), earlier studies recruiting clinical 
malaria cases may have overestimated gametocyte preva-
lence by molecular assays. In studies with asymptomatic 
parasite carriers and in low-endemic settings, where 
lower asexual parasite densities dominate, this overesti-
mation will be less pronounced and often negligible. A 
previously reported rapid decline in gametocyte preva-
lence based on Pf25 mRNA detection in the first 3 days 
following treatment of high-density asexual infections 
[45] may thus be (partially) explained by the detection 
of Pfs25 transcripts arising from asexual parasites, whilst 
the gradual decline in gametocyte prevalence following 
treatment of lower-density asymptomatic asexual para-
site carriers [15, 46] or gametocyte transcript kinetics in 
the period following asexual parasite clearance may bet-
ter reflect gametocyte clearance and gametocyte half-life 
[47]. With a better appreciation of caveats in gametocyte 
detection, the molecular tools for gametocyte detection 
are of value for studies aiming to quantify the human 
infectious reservoir for malaria, the kinetics of game-
tocyte production and the impact of interventions on 
gametocyte carriage. As a consequence of the detection 
of low level transcripts of gametocyte markers in rings, 
it is advised to report gametocyte prevalence in sam-
ples with parasite densities > 1000 parasites/µL together 
with a qualifying remark on the reliability of gametocyte 
prevalence and quantification. The presented results sug-
gest that gametocyte prevalence determined in samples 
below assay-specific cut-off values indeed can be trusted 
(Table  3). Stating the limitations of molecularly deter-
mined gametocyte prevalence for densities, if required, 
will re-confirm the validity of molecular gametocyte 
detection.
With a cautious interpretation of low gametocyte den-
sity estimates in samples with high concurrent asexual 
parasite densities, molecular gametocyte diagnostics 
such as the multiplex assay presented in this manuscript 
are valuable tools to obtain sensitive and robust esti-
mates of gametocyte prevalence and density. With these 
tools, gametocyte densities and sex ratios can be assessed 
across the gametocyte density range that is likely to con-
tribute to onward transmission to mosquitoes [7, 19], 
which in many settings is well below the threshold for 
detection by microscopy.
Conclusion
The presented multiplex qPCR assay is a valuable addi-
tion to gametocyte diagnostic tools. A new female 
gametocyte marker gene, CCp4 was introduced and 
benchmarked against Pfs25 transcript-based quantifi-
cation. The use of CCp4 and PfMGET as targets has the 
following advantages: throughput is facilitated by the use 
of intron-spanning primers which allow amplification of 
mRNA only without a DNA digestion step, sensitivity 
is sufficiently high to detect and quantify all potentially 
transmitting gametocyte densities. The target mRNAs 
result in a similar detectability of male and female game-
tocytes and show similar stability under suboptimal stor-
age conditions, allowing robust gametocyte sex-ratio 
estimates in field studies.
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